Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up

Leukemia. 2010 May;24(5):1050-2. doi: 10.1038/leu.2010.12. Epub 2010 Feb 11.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Middle Aged
  • Myeloablative Agonists / therapeutic use*
  • Myelodysplastic Syndromes / therapy*
  • Survival Rate
  • Time Factors
  • Transplantation Conditioning*
  • Transplantation, Homologous
  • Treatment Outcome
  • Young Adult

Substances

  • Myeloablative Agonists